Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)-Reference-Cited by-同舟云学术

Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)

Published:2016-06 Issue:6 Volume:123 Page:1399-1401
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Fraser-Bell Samantha,Lim Lyndell L.,Campain Anna,Mehta Hemal,Aroney Christine,Bryant Jaclyn,Li Ji,Quin Godfrey J.,McAllister Ian L.,Gillies Mark C.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference5 articles.

1. Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema;Mehta;Ther Adv Chronic Dis,2015

2. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study;Gillies;Ophthalmology,2014

3. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3;Rajendram;Arch Ophthalmol,2012

4. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2011

5. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial;Mehta;Br J Ophthalmol,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immediate response to intravitreal treatment for macular edema due to diabetes and retinal vein occlusion;European Journal of Ophthalmology;2024-05-20

2. Diabetic Disease of the Eye in Canada: Consensus Statements from a Retina Specialist Working Group;Ophthalmology and Therapy;2024-03-23

3. Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study;Journal of Translational Medicine;2024-03-22

4. Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema;Patient Preference and Adherence;2023-12

5. RWC Update: Macular Indentation to Manage Complications of Pathological Myopia; OCT Biomarker Based Decision Making in the Management of Diabetic Macular Edema; Scleritis With Chorioretinal Folds;Ophthalmic Surgery, Lasers and Imaging Retina;2023-11